Biogen, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US09062X1037
USD
181.98
1.8 (1.0%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
2,561.50
2,336.00
2,337.60
2,375.70
2,353.00
2,200.30
2,299.50
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,561.50
2,336.00
2,337.60
2,375.70
2,353.00
2,200.30
2,299.50
Raw Material Cost
799.30
812.50
807.50
821.50
704.80
689.80
758.40
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
72.60
60.00
60.00
59.80
61.30
69.20
71.50
Selling and Distribution Expenses
583.80
572.50
680.00
588.40
553.80
581.50
608.50
Other Expenses
25.95
30.27
39.95
41.02
38.07
31.44
43.59
Total Expenditure (Excl Depreciation)
1,715.20
1,747.70
1,947.00
1,879.90
1,700.60
1,654.90
1,874.30
Operating Profit (PBDIT) excl Other Income
846.3
588.3
390.6
495.79999999999995
652.4
545.4
425.20000000000005
Other Income
6.00
35.80
-72.20
39.50
119.00
18.10
61.80
Operating Profit (PBDIT)
1,046.60
807.30
542.40
718.10
930.20
711.10
627.10
Interest
72.60
60.00
60.00
59.80
61.30
69.20
71.50
Exceptional Items
-35.70
-252.90
2.30
-24.50
-11.40
-29.50
-123.90
Gross Profit (PBDT)
1,762.20
1,523.50
1,530.10
1,554.20
1,648.20
1,510.50
1,541.10
Depreciation
194.30
183.20
224.00
182.80
158.80
147.60
140.10
Profit Before Tax
744.00
311.20
291.50
451.00
698.70
464.80
291.60
Tax
109.20
70.70
24.70
62.50
115.10
71.40
42.70
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
634.80
240.50
266.80
388.50
583.60
393.40
249.70
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
634.80
240.50
266.80
388.50
583.60
393.40
249.70
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
-0.80
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
634.80
240.50
266.80
388.50
583.60
393.40
248.90
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
17,634.00
16,978.70
16,716.00
16,358.90
15,889.10
15,213.00
14,799.40
Earnings per share (EPS)
4.33
1.64
1.83
2.66
4.0
2.7
1.71
Diluted Earnings per share
4.33
1.64
1.83
2.66
4.0
2.7
1.71
Operating Profit Margin (Excl OI)
33.04%
25.18%
16.71%
20.87%
27.73%
24.79%
18.49%
Gross Profit Margin
36.63%
21.16%
22.05%
26.68%
36.44%
27.83%
18.77%
PAT Margin
24.78%
10.3%
11.41%
16.35%
24.8%
17.88%
10.86%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 9.65% vs -0.07% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is 163.95% vs -9.86% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is 34.88% vs 25.53% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 21.00% vs 0.00% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

Compare Quarterly Results Of Biogen, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
2,561.50
142.00
2,419.50
1,703.87%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,561.50
142.00
2,419.50
1,703.87%
Raw Material Cost
799.30
176.00
623.30
354.15%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
72.60
1.00
71.60
7,160.00%
Selling and Distribution Expenses
583.80
230.00
353.80
153.83%
Other Expenses
25.95
64.20
-38.25
-59.58%
Total Expenditure (Excl Depreciation)
1,715.20
1,049.00
666.20
63.51%
Operating Profit (PBDIT) excl Other Income
846.30
-907.00
1,753.30
193.31%
Other Income
6.00
90.00
-84.00
-93.33%
Operating Profit (PBDIT)
1,046.60
-760.00
1,806.60
237.71%
Interest
72.60
1.00
71.60
7,160.00%
Exceptional Items
-35.70
0.00
-35.70
Gross Profit (PBDT)
1,762.20
-34.00
1,796.20
5,282.94%
Depreciation
194.30
57.00
137.30
240.88%
Profit Before Tax
744.00
-818.00
1,562.00
190.95%
Tax
109.20
7.00
102.20
1,460.00%
Provisions and contingencies
0
0
0.00
Profit After Tax
634.80
-825.00
1,459.80
176.95%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
634.80
-825.00
1,459.80
176.95%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
634.80
-825.00
1,459.80
176.95%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
17,634.00
9,399.00
8,235.00
87.62%
Earnings per share (EPS)
4.33
-2.13
6.46
303.29%
Diluted Earnings per share
4.33
-2.13
6.46
303.29%
Operating Profit Margin (Excl OI)
33.04%
-638.73%
0.00
671.77%
Gross Profit Margin
36.63%
-535.92%
0.00
572.55%
PAT Margin
24.78%
-580.99%
0.00
605.77%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 256.15 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 9.65% vs -0.07% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 8.86% vs 0.09% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 63.48 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 163.95% vs -9.86% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 8.77% vs -1.63% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 104.06 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 34.88% vs 25.53% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 28.28% vs 17.46% in Jun 2024

Quarterly - Interest
Interest 7.26 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 21.00% vs 0.00% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 18.43% vs 24.85% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 33.04%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024